Skip to main content

Resection of Metachronous Colorectal Cancer Liver Metastases: Surgical Outcomes

  • Chapter
  • First Online:
Colorectal Cancer Liver Metastases

Abstract

The burden of colorectal cancer (CRC) is still increasing worldwide. Treatment of colorectal liver metastases (CRLM) is essential for long-term survival. CRLM are classified as synchronous or metachronous according to the timing of diagnosis in relation to the primary tumor. Synchronous lesions are associated with worse overall and surgical prognosis. Factors associated with poor survival in CRLM patients are age 60 years, 2 lesions, extrahepatic disease, lesion size >5 cm, positive lymph nodes near primary tumor, elevated carcinoembryonic antigen levels, absence of adjuvant treatment, resection with positive margins, and palliative treatment. Recurrence after hepatectomy is frequent; the time between liver surgery and recurrence is an important prognostic marker. To achieve the best possible long-term results, surgery with curative intent should be the rule, even with recurrent disease. Prognostic scores should be used with caution when making decisions regarding surgery but may be useful to identify candidates for chemotherapy. In this chapter, we will emphasize the outcomes and other aspects of metachronous metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. https://doi.org/10.3322/caac.21442.

    Article  PubMed  Google Scholar 

  2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser C, Mathers M et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon, France. 2013. http://globocan.iarc.fr.

  3. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–91. https://doi.org/10.1136/gutjnl-2015-310912.

    Article  PubMed  Google Scholar 

  4. Maher B, Ryan E, Little M, Boardman P, Stedman B. The management of colorectal liver metastases. Clin Radiol. 2017;72(8):617–25. https://doi.org/10.1016/j.crad.2017.05.016.

    Article  CAS  PubMed  Google Scholar 

  5. Jones RP, Kokudo N, Folprecht G, Mise Y, Unno M, Malik HZ, et al. Colorectal liver metastases: a critical review of state of the art. Liver Cancer. 2016;6(1):66–71. https://doi.org/10.1159/000449348.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Jeong S, Heo JS, Park JY, Choi DW, Choi SH. Surgical resection of synchronous and metachronous lung and liver metastases of colorectal cancers. Ann Surg Treat Res. 2017;92(2):82–9. https://doi.org/10.4174/astr.2017.92.2.82.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Angelsen JH, Horn A, Sorbye H, Eide GE, Loes IM, Viste A. Population-based study on resection rates and survival in patients with colorectal liver metastasis in Norway. Br J Surg. 2017;104(5):580–9. https://doi.org/10.1002/bjs.10457.

    Article  PubMed  Google Scholar 

  8. Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg. 1986;73(9):727–31.

    Article  CAS  PubMed  Google Scholar 

  9. Adam R, Frilling A, Elias D, Laurent C, Ramos E, Capussotti L, et al. Liver resection of colorectal metastases in elderly patients. Br J Surg. 2010;97(3):366–76. https://doi.org/10.1002/bjs.6889.

    Article  CAS  PubMed  Google Scholar 

  10. Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41(9):729–41. https://doi.org/10.1016/j.ctrv.2015.06.006.

    Article  PubMed  Google Scholar 

  11. Slesser AA, Georgiou P, Brown G, Mudan S, Goldin R, Tekkis P. The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review. Clin Exp Metastasis. 2013;30(4):457–70. https://doi.org/10.1007/s10585-012-9551-8.

    Article  CAS  PubMed  Google Scholar 

  12. Bird NC, Mangnall D, Majeed AW. Biology of colorectal liver metastases: a review. J Surg Oncol. 2006;94(1):68–80. https://doi.org/10.1002/jso.20558.

    Article  CAS  PubMed  Google Scholar 

  13. Wang SC, Lin JK, Wang HS, Yang SH, Li AF, Chang SC. Nuclear expression of CXCR4 is associated with advanced colorectal cancer. Int J Color Dis. 2010;25(10):1185–91. https://doi.org/10.1007/s00384-010-0999-1.

    Article  Google Scholar 

  14. Rudmik LR, Magliocco AM. Molecular mechanisms of hepatic metastasis in colorectal cancer. J Surg Oncol. 2005;92(4):347–59. https://doi.org/10.1002/jso.20393.

    Article  CAS  PubMed  Google Scholar 

  15. Li JQ, Miki H, Wu F, Saoo K, Nishioka M, Ohmori M, et al. Cyclin a correlates with carcinogenesis and metastasis, and p27(kip1) correlates with lymphatic invasion, in colorectal neoplasms. Hum Pathol. 2002;33(10):1006–15.

    Article  CAS  PubMed  Google Scholar 

  16. Thomas GV, Szigeti K, Murphy M, Draetta G, Pagano M, Loda M. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol. 1998;153(3):681–7. https://doi.org/10.1016/S0002-9440(10)65610-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC, et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999;154(2):313–23. https://doi.org/10.1016/S0002-9440(10)65277-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Li JQ, Miki H, Ohmori M, Wu F, Funamoto Y. Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma. Hum Pathol. 2001;32(9):945–53. https://doi.org/10.1053/hupa.2001.27116.

    Article  CAS  PubMed  Google Scholar 

  19. Kobayashi H, Sugihara K, Uetake H, Higuchi T, Yasuno M, Enomoto M, et al. Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis. Int J Oncol. 2008;33(6):1257–62.

    CAS  PubMed  Google Scholar 

  20. Inokuchi M, Uetake H, Shirota Y, Yamada H, Tajima M, Sugihara K. Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis. Cancer Chemother Pharmacol. 2004;53(5):391–6. https://doi.org/10.1007/s00280-003-0747-0.

    Article  CAS  PubMed  Google Scholar 

  21. Ghadjar P, Coupland SE, Na IK, Noutsias M, Letsch A, Stroux A, et al. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J Clin Oncol. 2006;24(12):1910–6. https://doi.org/10.1200/JCO.2005.04.1822.

    Article  CAS  PubMed  Google Scholar 

  22. Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol. 2005;23(12):2744–53. https://doi.org/10.1200/JCO.2005.07.078.

    Article  CAS  PubMed  Google Scholar 

  23. Ghadjar P, Rubie C, Aebersold DM, Keilholz U. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int J Cancer. 2009;125(4):741–5. https://doi.org/10.1002/ijc.24468.

    Article  CAS  PubMed  Google Scholar 

  24. Wu Y, Jin M, Xu H, Shimin Z, He S, Wang L, et al. Clinicopathologic significance of HIF-1alpha, CXCR4, and VEGF expression in colon cancer. Clin Dev Immunol. 2010;2010:1. https://doi.org/10.1155/2010/537531.

    Article  CAS  Google Scholar 

  25. Kim YW, Ko YT, Kim NK, Chung HC, Min BS, Lee KY, et al. A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: the significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis. Scand J Gastroenterol. 2010;45(2):217–25. https://doi.org/10.3109/00365520903453158.

    Article  CAS  PubMed  Google Scholar 

  26. Esposito DL, Aru F, Lattanzio R, Morgano A, Abbondanza M, Malekzadeh R, et al. The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. PLoS One. 2012;7(4):e36190. https://doi.org/10.1371/journal.pone.0036190.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Bommer GT, Feng Y, Iura A, Giordano TJ, Kuick R, Kadikoy H, et al. IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype. J Biol Chem. 2010;285(3):1928–38. https://doi.org/10.1074/jbc.M109.060319.

    Article  CAS  PubMed  Google Scholar 

  28. Ayaki M, Komatsu K, Mukai M, Murata K, Kameyama M, Ishiguro S, et al. Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. Clin Cancer Res. 2001;7(10):3106–12.

    CAS  PubMed  Google Scholar 

  29. Yamauchi T, Watanabe M, Kubota T, Hasegawa H, Ishii Y, Endo T, et al. Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer. Dis Colon Rectum. 2002;45(1):98–103.

    Article  PubMed  Google Scholar 

  30. Watanabe T, Kobunai T, Yamamoto Y, Kanazawa T, Konishi T, Tanaka T, et al. Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes. Eur J Cancer. 2010;46(11):2119–26. https://doi.org/10.1016/j.ejca.2010.04.019.

    Article  CAS  PubMed  Google Scholar 

  31. Nakamoto RH, Uetake H, Iida S, Kolev YV, Soumaoro LT, Takagi Y, et al. Correlations between cyclooxygenase-2 expression and angiogenic factors in primary tumors and liver metastases in colorectal cancer. Jpn J Clin Oncol. 2007;37(9):679–85. https://doi.org/10.1093/jjco/hym080.

    Article  PubMed  Google Scholar 

  32. Pantaleo MA, Astolfi A, Nannini M, Paterini P, Piazzi G, Ercolani G, et al. Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice. Br J Cancer. 2008;99(10):1729–34. https://doi.org/10.1038/sj.bjc.6604681.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Prabhudesai SG, Rekhraj S, Roberts G, Darzi AW, Ziprin P. Apoptosis and chemo-resistance in colorectal cancer. J Surg Oncol. 2007;96(1):77–88. https://doi.org/10.1002/jso.20785.

    Article  CAS  PubMed  Google Scholar 

  34. De Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw AS, Sluiter WJ, et al. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology. 1998;28(4):971–9. https://doi.org/10.1002/hep.510280411.

    Article  PubMed  Google Scholar 

  35. Miyagawa S, Soeda J, Takagi S, Miwa S, Ichikawa E, Noike T. Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer. Hum Pathol. 2004;35(11):1392–6. https://doi.org/10.1016/j.humpath.2004.07.018.

    Article  PubMed  Google Scholar 

  36. van der Wal GE, Gouw AS, Kamps JA, Moorlag HE, Bulthuis ML, Molema G, et al. Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil. Ann Surg. 2012;255(1):86–94. https://doi.org/10.1097/SLA.0b013e318238346a.

    Article  PubMed  Google Scholar 

  37. Venderbosch S, de Wilt JH, Teerenstra S, Loosveld OJ, van Bochove A, Sinnige HA, et al. Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol. 2011;18(12):3252–60. https://doi.org/10.1245/s10434-011-1951-5.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Wang K, Liu W, Yan XL, Li J, Xing BC. Long-term postoperative survival prediction in patients with colorectal liver metastasis. Oncotarget. 2017;8(45):79927–34. https://doi.org/10.18632/oncotarget.20322.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Graf W, Bergstrom R, Pahlman L, Glimelius B. Appraisal of a model for prediction of prognosis in advanced colorectal cancer. Eur J Cancer. 1994;30A(4):453–7.

    Article  CAS  PubMed  Google Scholar 

  40. Freyer G, Rougier P, Bugat R, Droz JP, Marty M, Bleiberg H, et al. Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups. Br J Cancer. 2000;83(4):431–7. https://doi.org/10.1054/bjoc.2000.1303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Etienne-Grimaldi MC, Formento JL, Francoual M, Francois E, Formento P, Renee N, et al. K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy. Clin Cancer Res. 2008;14(15):4830–5. https://doi.org/10.1158/1078-0432.CCR-07-4906.

    Article  CAS  PubMed  Google Scholar 

  42. Tsai MS, Su YH, Ho MC, Liang JT, Chen TP, Lai HS, et al. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol. 2007;14(2):786–94. https://doi.org/10.1245/s10434-006-9215-5.

    Article  PubMed  Google Scholar 

  43. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254–9. https://doi.org/10.1097/01.sla.0000217629.94941.cf.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Ghiringhelli F, Hennequin A, Drouillard A, Lepage C, Faivre J, Bouvier AM. Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based study. Dig Liver Dis. 2014;46(9):854–8. https://doi.org/10.1016/j.dld.2014.05.011.

    Article  PubMed  Google Scholar 

  45. Mekenkamp LJ, Koopman M, Teerenstra S, van Krieken JH, Mol L, Nagtegaal ID, et al. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. Br J Cancer. 2010;103(2):159–64. https://doi.org/10.1038/sj.bjc.6605737.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. van der Pool AE, Lalmahomed ZS, Ozbay Y, de Wilt JH, Eggermont AM, Jzermans JN, et al. ‘Staged’ liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome. Colorectal Dis. 2010;12(10 Online):e229–35. https://doi.org/10.1111/j.1463-1318.2009.02135.x.

    Article  PubMed  Google Scholar 

  47. Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg. 2006;93(4):465–74. https://doi.org/10.1002/bjs.5278.

    Article  CAS  PubMed  Google Scholar 

  48. Engstrand J, Nilsson H, Stromberg C, Jonas E, Freedman J. Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer. 2018;18(1):78. https://doi.org/10.1186/s12885-017-3925-x.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Swan PJ, Welsh FK, Chandrakumaran K, Rees M. Long-term survival following delayed presentation and resection of colorectal liver metastases. Br J Surg. 2011;98(9):1309–17. https://doi.org/10.1002/bjs.7527.

    Article  CAS  PubMed  Google Scholar 

  50. Hackl C, Neumann P, Gerken M, Loss M, Klinkhammer-Schalke M, Schlitt HJ. Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer. 2014;14:810. https://doi.org/10.1186/1471-2407-14-810.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Wang X, Hershman DL, Abrams JA, Feingold D, Grann VR, Jacobson JS, et al. Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br J Cancer. 2007;97(12):1606–12. https://doi.org/10.1038/sj.bjc.6604093.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg. 1995;19(1):59–71.

    Article  CAS  PubMed  Google Scholar 

  53. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996;77(7):1254–62.

    Article  CAS  PubMed  Google Scholar 

  54. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309–18; discussion 18–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Sadot E, Groot Koerkamp B, Leal JN, Shia J, Gonen M, Allen PJ, et al. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? Ann Surg. 2015;262(3):476–85.; ; discussion 83–5. https://doi.org/10.1097/SLA.0000000000001427.

    Article  PubMed  Google Scholar 

  56. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247(1):125–35. https://doi.org/10.1097/SLA.0b013e31815aa2c2.

    Article  PubMed  Google Scholar 

  57. Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, Gomez D, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg. 2007;246(5):806–14. https://doi.org/10.1097/SLA.0b013e318142d964.

    Article  PubMed  Google Scholar 

  58. Figueras J, Torras J, Valls C, Llado L, Ramos E, Marti-Rague J, et al. Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients. Dis Colon Rectum. 2007;50(4):478–88. https://doi.org/10.1007/s10350-006-0817-6.

    Article  PubMed  Google Scholar 

  59. Weber JC, Nakano H, Bachellier P, Oussoultzoglou E, Inoue K, Shimura H, et al. Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? Am J Surg. 2001;182(1):81–8.

    Article  CAS  PubMed  Google Scholar 

  60. Vigano L, Capussotti L, Lapointe R, Barroso E, Hubert C, Giuliante F, et al. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol. 2014;21(4):1276–86. https://doi.org/10.1245/s10434-013-3421-8.

    Article  PubMed  Google Scholar 

  61. Ng WW, Cheung YS, Wong J, Lee KF, Lai PB. A preliminary analysis of combined liver resection with new chemotherapy for synchronous and metachronous colorectal liver metastasis. Asian J Surg. 2009;32(4):189–97. https://doi.org/10.1016/S1015-9584(09)60394-8.

    Article  PubMed  Google Scholar 

  62. Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006;13(5):668–76. https://doi.org/10.1245/ASO.2006.05.039.

    Article  PubMed  Google Scholar 

  63. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241(5):715–22, discussion 22–4.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Nanji S, Cleary S, Ryan P, Guindi M, Selvarajah S, Al-Ali H, et al. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival. Ann Surg Oncol. 2013;20(1):295–304. https://doi.org/10.1245/s10434-012-2424-1.

    Article  PubMed  Google Scholar 

  65. de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg. 2009;250(3):440–8. https://doi.org/10.1097/SLA.0b013e3181b4539b.

    Article  PubMed  Google Scholar 

  66. Sugawara Y, Yamamoto J, Yamasaki S, Shimada K, Kosuge T, Makuuchi M. Estimating the prognosis of hepatic resection in patients with metastatic liver tumors from colorectal cancer with special concern for the timing of hepatectomy. Surgery. 2001;129(4):408–13. https://doi.org/10.1067/msy.2001.112001.

    Article  CAS  PubMed  Google Scholar 

  67. Adam R, Bismuth H, Castaing D, Waechter F, Navarro F, Abascal A, et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg. 1997;225(1):51–60; discussion −2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Hallet J, Sa Cunha A, Adam R, Goere D, Bachellier P, Azoulay D, et al. Factors influencing recurrence following initial hepatectomy for colorectal liver metastases. Br J Surg. 2016;103(10):1366–76. https://doi.org/10.1002/bjs.10191.

    Article  CAS  PubMed  Google Scholar 

  69. Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 1999;189(3):291–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Xu J, Wei Y, Zhong Y, Fan J, Zhou J, Qin L, et al. Hepatectomy for liver metastasis of colorectal cancer. Int J Color Dis. 2009;24(4):419–25. https://doi.org/10.1007/s00384-008-0619-5.

    Article  Google Scholar 

  71. Ito H, Are C, Gonen M, D'Angelica M, Dematteo RP, Kemeny NE, et al. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008;247(6):994–1002. https://doi.org/10.1097/SLA.0b013e31816c405f.

    Article  PubMed  Google Scholar 

  72. Angelsen JH, Viste A, Loes IM, Eide GE, Hoem D, Sorbye H, et al. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases. World J Surg Oncol. 2015;13:328. https://doi.org/10.1186/s12957-015-0738-8.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Imai K, Allard MA, Benitez CC, Vibert E, Sa Cunha A, Cherqui D, et al. Early recurrence after hepatectomy for colorectal liver metastases: what optimal definition and what predictive factors? Oncologist. 2016;21(7):887–94. https://doi.org/10.1634/theoncologist.2015-0468.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Takahashi S, Konishi M, Nakagohri T, Gotohda N, Saito N, Kinoshita T. Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis. Jpn J Clin Oncol. 2006;36(6):368–75. https://doi.org/10.1093/jjco/hyl027.

    Article  PubMed  Google Scholar 

  75. Bozzetti F, Doci R, Bignami P, Morabito A, Gennari L. Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg. 1987;205(3):264–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Beppu T, Sakamoto Y, Hasegawa K, Honda G, Tanaka K, Kotera Y, et al. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a project study for hepatic surgery of the Japanese society of Hepato-biliary-pancreatic surgery. J Hepatobiliary Pancreat Sci. 2012;19(1):72–84. https://doi.org/10.1007/s00534-011-0460-z.

    Article  PubMed  Google Scholar 

  77. Ishizuka D, Shirai Y, Sakai Y, Hatakeyama K. Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels. Int J Color Dis. 2001;16(1):32–7.

    Article  CAS  Google Scholar 

  78. Lu Z, Peng J, Wang Z, Pan Z, Yuan Y, Wan D, et al. High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection. Med Oncol. 2016;33(11):121. https://doi.org/10.1007/s12032-016-0838-5.

    Article  CAS  PubMed  Google Scholar 

  79. Vigano L, Procopio F, Cimino MM, Donadon M, Gatti A, Costa G, et al. Is tumor detachment from vascular structures equivalent to R0 resection in surgery for colorectal liver metastases? An Observational Cohort. Ann Surg Oncol. 2016;23(4):1352–60. https://doi.org/10.1245/s10434-015-5009-y.

    Article  PubMed  Google Scholar 

  80. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371(9617):1007–16. https://doi.org/10.1016/S0140-6736(08)60455-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Wurster EF, Tenckhoff S, Probst P, Jensen K, Dolger E, Knebel P, et al. A systematic review and meta-analysis of the utility of repeated versus single hepatic resection for colorectal cancer liver metastases. HPB (Oxford). 2017;19(6):491–7. https://doi.org/10.1016/j.hpb.2017.02.440.

    Article  Google Scholar 

  82. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25(29):4575–80. https://doi.org/10.1200/JCO.2007.11.0833.

    Article  PubMed  Google Scholar 

  83. Vigano L, Ferrero A, Lo Tesoriere R, Capussotti L. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol. 2008;15(9):2458–64. https://doi.org/10.1245/s10434-008-9935-9.

    Article  PubMed  Google Scholar 

  84. Pulitano C, Castillo F, Aldrighetti L, Bodingbauer M, Parks RW, Ferla G, et al. What defines ‘cure’ after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford). 2010;12(4):244–9. https://doi.org/10.1111/j.1477-2574.2010.00155.x.

    Article  Google Scholar 

  85. Adam R, Wicherts DA, de Haas RJ, Ciacio O, Levi F, Paule B, et al. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol. 2009;27(11):1829–35. https://doi.org/10.1200/JCO.2008.19.9273.

    Article  PubMed  Google Scholar 

  86. Imai K, Castro Benitez C, Allard MA, Vibert E, Sa Cunha A, Cherqui D, et al. Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease. J Surg Oncol. 2017;115(4):488–96. https://doi.org/10.1002/jso.24539.

    Article  CAS  PubMed  Google Scholar 

  87. Cucchetti A, Ferrero A, Cescon M, Donadon M, Russolillo N, Ercolani G, et al. Cure model survival analysis after hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2015;22(6):1908–14. https://doi.org/10.1245/s10434-014-4234-0.

    Article  PubMed  Google Scholar 

  88. Nagashima I, Takada T, Nagawa H, Muto T, Okinaga K. Proposal of a new and simple staging system of colorectal liver metastasis. World J Gastroenterol. 2006;12(43):6961–5.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Konopke R, Kersting S, Distler M, Dietrich J, Gastmeier J, Heller A, et al. Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int. 2009;29(1):89–102. https://doi.org/10.1111/j.1478-3231.2008.01845.x.

    Article  PubMed  Google Scholar 

  90. Zakaria S, Donohue JH, Que FG, Farnell MB, Schleck CD, Ilstrup DM, et al. Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg. 2007;246(2):183–91. https://doi.org/10.1097/SLA.0b013e3180603039.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati P. Patterns of recurrence after resection of colorectal liver metastases: prediction by models of outcome analysis. World J Surg. 2001;25(5):638–44. https://doi.org/10.1007/s002680020138.

    Article  CAS  PubMed  Google Scholar 

  92. Ueno H, Mochizuki H, Hatsuse K, Hase K, Yamamoto T. Indicators for treatment strategies of colorectal liver metastases. Ann Surg. 2000;231(1):59–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Schindl M, Wigmore SJ, Currie EJ, Laengle F, Garden OJ. Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg. 2005;140(2):183–9. https://doi.org/10.1001/archsurg.140.2.183.

    Article  PubMed  Google Scholar 

  94. Kanemitsu Y, Kato T. Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer. World J Surg. 2008;32(6):1097–107. https://doi.org/10.1007/s00268-007-9348-0.

    Article  PubMed  Google Scholar 

  95. Mann CD, Metcalfe MS, Leopardi LN, Maddern GJ. The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg. 2004;139(11):1168–72. https://doi.org/10.1001/archsurg.139.11.1168.

    Article  PubMed  Google Scholar 

  96. Mala T, Bohler G, Mathisen O, Bergan A, Soreide O. Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg. 2002;26(11):1348–53. https://doi.org/10.1007/s00268-002-6231-x.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fábio Luiz Waechter .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Waechter, F.L., Teixeira, U.F., Rodrigues, P.D., Boff, M., Danesi, R., Correia, M.M. (2020). Resection of Metachronous Colorectal Cancer Liver Metastases: Surgical Outcomes. In: Correia, M., Choti, M., Rocha, F., Wakabayashi, G. (eds) Colorectal Cancer Liver Metastases. Springer, Cham. https://doi.org/10.1007/978-3-030-25486-5_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25486-5_27

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25485-8

  • Online ISBN: 978-3-030-25486-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics